A comprehensive framework for glioma surgery by the PIONEER Consortium and RANO resect group, part 1: intraoperative recommendations for mapping, monitoring, and decision making (2026) Gerritsen JK, Karschnia P, Bello L, Hervey-Jumper S, Young JS, Seidel K, Satoer DD, et al. Journal article, Review article A comprehensive framework for glioma surgery by the PIONEER Consortium and RANO resect group, part 2: perioperative recommendations for neurological, language, functional, and quality-of-life assessment (2026) Gerritsen JK, Karschnia P, Bello L, Hervey-Jumper S, Young JS, Seidel K, Satoer DD, et al. Journal article, Review article Distant disease-free survival as a surrogate endpoint for overall survival in randomised trials of neoadjuvant therapy for early breast cancer: a pooled analysis of GBG and AGO-B Study Group trials (2025) Conforti F, Holtschmidt J, Nekljudova V, Sala I, Pagan E, Solbach C, Untch M, et al. Journal article A prognostic classification system for extent of resection in IDH-mutant grade 2 glioma: an international, multicentre, retrospective cohort study with external validation by the RANO resect group (2025) Karschnia P, Young JS, Wijnenga MM, Sciortino T, Teske N, Corell A, Wagner A, et al. Journal article [68Ga]Ga-FAPI-46 PET accuracy for cancer imaging with histopathology validation: a single-centre, single-arm, interventional, phase 2 trial (2025) Pabst KM, Weber MM, Laschinsky C, Sandach P, Bartel T, Küper AT, Kessler L, et al. Journal article Neoadjuvant or perioperative therapy for melanoma metastasis in clinical practice: an international survey. (2025) Hauschild A, Garbe C, Ascierto PA, Demidov L, Dreno B, Dummer R, Eggermont A, et al. Journal article Single-modality endocrine therapy versus radiotherapy after breast-conserving surgery in women aged 70 years and older with luminal A-like early breast cancer (EUROPA): a preplanned interim analysis of a phase 3, non-inferiority, randomised trial (2025) Meattini I, De Santis MC, Visani L, Scorsetti M, Fozza A, Meduri B, De Rose F, et al. Journal article A brave new framework for glioma drug development (2024) Hotchkiss KM, Karschnia P, Schreck KC, Geurts M, Cloughesy TF, Huse J, Duke ES, et al. Journal article, Review article The oncological role of resection in newly diagnosed diffuse adult-type glioma defined by the WHO 2021 classification: a Review by the RANO resect group (2024) Karschnia P, Gerritsen JK, Teske N, Cahill DP, Jakola AS, van den Bent M, Weller M, et al. Journal article, Review article Irinotecan and temozolomide in combination with dasatinib and rapamycin versus irinotecan and temozolomide for patients with relapsed or refractory neuroblastoma (RIST-rNB-2011): a multicentre, open-label, randomised, controlled, phase 2 trial (2024) Corbacioglu S, Lode H, Ellinger S, Zeman F, Suttorp M, Escherich G, Bochennek K, et al. Journal article